Canadian Hospital Specialties Welcomes Flexpoint Ford as Strategic Investor
Investment Provides CHS With Resources to Expand Existing Business While Continuing to Provide Customers with Leading Patient Care Solutions
News provided by
Share this article
Share this article
OAKVILLE, ON and CHICAGO, April 22, 2021 /PRNewswire/ Canadian Hospital Specialties Ltd. ( CHS ), a leading specialty distributor and manufacturer of medical and surgical products, announced today it has received a strategic investment from Flexpoint Ford ( Flexpoint ), a private equity investment firm specializing in the healthcare and financial services industries. Previously majority-owned by affiliates of Cortec Group, CHS will continue operating as an independent company led by CEO Mike Canzoneri and the company s current management team, who will continue to be owners in the business. The company will remain headquartered in Oakville, Ontario.
Press release content from Business Wire. The AP news staff was not involved in its creation.
IMBiotechnologies Ltd. Announces Agreement with Canadian Hospital Specialties to Distribute Ekobi® Embolization Microspheres in Canada
January 21, 2021 GMT
EDMONTON, Alberta (BUSINESS WIRE) Jan 21, 2021
IMBiotechnologies Ltd. (“IMB” or the “Company”) today announced that it has signed an agreement with Canadian Hospital Specialties (“CHS”) for the exclusive right to distribute Ekobi® Embolization Microspheres (“Ekobi”) in Canada.
“CHS has expertise in the distribution of a broad range of medical devices, including interventional products,” said Michael Stewart, CEO of IMB. “We look forward to working with CHS to bring Ekobi to hospitals and clinics across Canada.”